Literature DB >> 2994287

Ultrastructural studies of adrenal adenoma causing primary aldosteronism.

H Kuramoto, J Kumazawa.   

Abstract

Adrenal adenoma tissue was obtained from 7 patients with the diagnosis of primary aldosteronism and was studied electron microscopically. Spironolactone was administered in 6 of these patients, but not in the remaining patient. Most of the mitochondria of the tumour cells possessed tubular cristae, giving an appearance similar to the mitochondria in the cells of the zona glomerulosa. Spironolactone bodies were seen in the tumour cells of 6 patients who were given spironolactone preoperatively, but were not observed in these cells in the patient not given spironolactone. The literature on the developmental mechanism of this spironolactone body was reviewed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994287     DOI: 10.1007/bf00710652

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  24 in total

1.  [ELECTRON MICROSCOPY OF THE ADRENAL CORTEX IN PRIMARY ALDOSTERONISM].

Authors:  A PROPST
Journal:  Beitr Pathol Anat       Date:  1965-01

2.  Spironolactone bodies in an adrenal adenoma.

Authors:  S S Shrago; J Waisman; P H Cooper
Journal:  Arch Pathol       Date:  1975-08

3.  Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.

Authors:  J W Conn; D L Hinerman
Journal:  Metabolism       Date:  1977-12       Impact factor: 8.694

4.  Spironolactone inclusions in an aldosteronoma.

Authors:  D R Cain; R L Van de Velde; S J Shapiro
Journal:  Am J Clin Pathol       Date:  1974-03       Impact factor: 2.493

5.  Electron microscopic studies on various types of inclusions found in autopsy cases. II. Spironolactone inclusion body in autopsy cases and its experimental studies on rhesus monkey.

Authors:  K Okano; K Yamashita; S Kyo; R Hama; K Nakano
Journal:  Med J Osaka Univ       Date:  1972-12

6.  Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.

Authors:  J A Sundsfjord; P Marton; H Jorgensen; A Aakvaag
Journal:  J Clin Endocrinol Metab       Date:  1974-10       Impact factor: 5.958

7.  Aldosteronoma and nonfunctioning adrenal cortical adenoma. Comparative ultrastructural study.

Authors:  H Reidbord; E R Fisher
Journal:  Arch Pathol       Date:  1969-08

8.  Adrenal adenomata causing primary aldosteronism. An ultrastructural study of twenty five cases.

Authors:  K I Kano; S Sato; H Hama
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979

9.  OBSERVATIONS ON THE FINE STRUCTURE OF LUTEIN CELLS. II. THE EFFECTS OF HYPOPHYSECTOMY AND MAMMOTROPHIC HORMONE IN THE RAT.

Authors:  A C ENDERS; W R LYONS
Journal:  J Cell Biol       Date:  1964-07       Impact factor: 10.539

10.  Ovarian steroid cells. II. The lutein cell.

Authors:  E J Blanchette
Journal:  J Cell Biol       Date:  1966-12       Impact factor: 10.539

View more
  1 in total

1.  Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings.

Authors:  Kishan A Patel; Edward P Calomeni; Tibor Nadasdy; Debra L Zynger
Journal:  Diagn Pathol       Date:  2014-08-09       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.